UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Long-term safety and tolerability of apremilast in patients with psoriasis: Pooled safety analysis for ≥156 weeks from 2 phase 3, randomized, controlled trials (ESTEEM 1 and 2)

Journal of the American Academy of Dermatology, 2017-08, Vol.77 (2), p.310-317.e1

2017

Volltextzugriff (PDF)

Efficacy of apremilast in the treatment of moderate to severe psoriasis: a randomised controlled trial

The Lancet (British edition), 2012-08, Vol.380 (9843), p.738-746

2012

Volltextzugriff (PDF)

Improvement in general touch avoidance in patients with moderate‐to‐severe genital psoriasis treated with ixekizumab during a 52‐week, randomized, phase 3 clinical trial (IXORA‐Q)

JEADV clinical practice, 2023-06, Vol.2 (2), p.282-292

2023

Volltextzugriff (PDF)

Safety of selective IL‐23p19 inhibitors for the treatment of psoriasis

Journal of the European Academy of Dermatology and Venereology, 2019-09, Vol.33 (9), p.1676-1684

2019

Volltextzugriff (PDF)

Once-weekly d -cycloserine effects on negative symptoms and cognition in schizophrenia: An exploratory study

Schizophrenia research, 2008-12, Vol.106 (2), p.320-327

2008

Volltextzugriff (PDF)

AJC Editor's Consensus: Psoriasis and Coronary Artery Disease

The American journal of cardiology, 2008-12, Vol.102 (12), p.1631-1643

2008

Volltextzugriff (PDF)

Efficacy and safety of ixekizumab in a randomized, double‐blinded, placebo‐controlled phase IIIb study of patients with moderate‐to‐severe genital psoriasis

British journal of dermatology (1951), 2018-10, Vol.179 (4), p.844-852

2018

Volltextzugriff (PDF)

Use of Biologic Agents in Combination with Other Therapies for the Treatment of Psoriasis

American journal of clinical dermatology, 2014-12, Vol.15 (6), p.467-478

2014

Volltextzugriff (PDF)

Supportive Therapy for Schizophrenia: Possible Mechanisms and Implications for Adjunctive Psychosocial Treatments

Schizophrenia bulletin, 2004, Vol.30 (1), p.101-112

2004

Volltextzugriff (PDF)

Ixekizumab Improved Patient-Reported Genital Psoriasis Symptoms and Impact of Symptoms on Sexual Activity vs Placebo in a Randomized, Double-Blind Study

Journal of sexual medicine, 2018-11, Vol.15 (11), p.1645-1652

2018

Volltextzugriff (PDF)

An exploratory open-label trial of aripiprazole as an adjuvant to clozapine therapy in chronic schizophrenia

Acta psychiatrica Scandinavica, 2006-02, Vol.113 (2), p.142-147

2006

Volltextzugriff (PDF)

A double-blind, placebo-controlled trial of rosiglitazone for clozapine-induced glucose metabolism impairment in patients with Schizophrenia

Acta Psychiatrica Scandinavica, 2009-06, Vol.119 (6), p.457-465

2009

Volltextzugriff (PDF)

Psoriasis in children and women: addressing some special needs

Seminars in cutaneous medicine and surgery, 2014-03, Vol.33 (2 Suppl 2), p.S42-S44

Cather, Jennifer C

2014

Volltextzugriff (PDF)

Association of erythrodermic cutaneous T-cell lymphoma, superantigen-positive Staphylococcus aureus, and oligoclonal T-cell receptor Vβ gene expansion

Blood, 1997, Vol.89 (1), p.32-40

1997

Volltextzugriff (PDF)

Modulating T cell responses for the treatment of psoriasis: a focus on efalizumab

Expert opinion on biological therapy, 2003-04, Vol.3 (2), p.361-370

2003

Volltextzugriff (PDF)

A double-blind, placebo-controlled trial of sibutramine for clozapine-associated weight gain

Acta Psychiatrica Scandinavica, 2007-02, Vol.115 (2), p.101-105

2007

Volltextzugriff (PDF)

Proceedings of the 5th Annual Perspectives in Rheumatic Diseases

Seminars in arthritis and rheumatism, 2013-12, Vol.43 (3), p.416-419

2013

Volltextzugriff (PDF)

The Editor’s Roundtable: Psoriasis, Inflammation, and Coronary Artery Disease

The American journal of cardiology, 2008-04, Vol.101 (8), p.1119-1126

2008

Volltextzugriff (PDF)

Impact of ixekizumab treatment on skin‐related personal relationship difficulties in moderate‐to‐severe psoriasis patients: 12‐week results from two Phase 3 trials

Journal of the European Academy of Dermatology and Venereology, 2017-11, Vol.31 (11), p.1867-1875

2017

Volltextzugriff (PDF)

The efficacy of multiple courses of alefacept in patients with moderate to severe chronic plaque psoriasis

Journal of the American Academy of Dermatology, 2006, Vol.54 (1), p.61-63

2006

Volltextzugriff (PDF)

Efficacy of Secukinumab on Moderate-to-severe Plaque Psoriasis Affecting Different Body Regions: a Pooled Analysis of Four Phase 3 Studies

Dermatology and therapy, 2016-12, Vol.6 (4), p.639-647

2016

Volltextzugriff (PDF)

Extreme obesity may be linked to markers flanking the human OB gene

Diabetes (New York, N.Y.), 1996-05, Vol.45 (5), p.691-694

1996

Volltextzugriff (PDF)

EMERGING NEW THERAPIES FOR CUTANEOUS T-CELL LYMPHOMA

Dermatologic clinics, 2000, Vol.18 (1), p.147-156

2000

Volltextzugriff (PDF)

Ichthyosiform sarcoidosis

Journal of the American Academy of Dermatology, 1999-05, Vol.40 (5), p.862-865

1999

Volltextzugriff (PDF)

Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial

The Lancet (British edition), 2017-06, Vol.389 (10086), p.2287-2303

2017

Volltextzugriff (PDF)

1 – 25 von 200

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(174)
Mit Volltextzugriff
(144)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(131)
Life Sciences & Biomedicine
(107)
Humans
(100)
Male
(62)
Female
(61)
Psychiatry
(56)
Adult
(53)
Biological And Medical Sciences
(48)
Medical Sciences
(46)
Schizophrenia
(42)
Middle Aged
(40)
Dermatology
(33)
Psychology. Psychoanalysis. Psychiatry
(28)
Psychopathology. Psychiatry
(25)
Double-Blind Method
(24)
Schizophrenia - Drug Therapy
(24)
Treatment Outcome
(23)
Adult And Adolescent Clinical Studies
(22)
Psychoses
(21)
Physical Sciences
(20)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Long-term safety and tolerability of apremilast in patients with psoriasis: Pooled safety analysis for ≥156 weeks from 2 phase 3, randomized, controlled trials (ESTEEM 1 and 2)

Efficacy of apremilast in the treatment of moderate to severe psoriasis: a randomised controlled trial

Improvement in general touch avoidance in patients with moderate‐to‐severe genital psoriasis treated with ixekizumab during a 52‐week, randomized, phase 3 clinical trial (IXORA‐Q)

Safety of selective IL‐23p19 inhibitors for the treatment of psoriasis

Once-weekly d -cycloserine effects on negative symptoms and cognition in schizophrenia: An exploratory study

AJC Editor's Consensus: Psoriasis and Coronary Artery Disease

Efficacy and safety of ixekizumab in a randomized, double‐blinded, placebo‐controlled phase IIIb study of patients with moderate‐to‐severe genital psoriasis

Use of Biologic Agents in Combination with Other Therapies for the Treatment of Psoriasis

Supportive Therapy for Schizophrenia: Possible Mechanisms and Implications for Adjunctive Psychosocial Treatments

Ixekizumab Improved Patient-Reported Genital Psoriasis Symptoms and Impact of Symptoms on Sexual Activity vs Placebo in a Randomized, Double-Blind Study

An exploratory open-label trial of aripiprazole as an adjuvant to clozapine therapy in chronic schizophrenia

A double-blind, placebo-controlled trial of rosiglitazone for clozapine-induced glucose metabolism impairment in patients with Schizophrenia

Psoriasis in children and women: addressing some special needs

Association of erythrodermic cutaneous T-cell lymphoma, superantigen-positive Staphylococcus aureus, and oligoclonal T-cell receptor Vβ gene expansion

Modulating T cell responses for the treatment of psoriasis: a focus on efalizumab

A double-blind, placebo-controlled trial of sibutramine for clozapine-associated weight gain

Proceedings of the 5th Annual Perspectives in Rheumatic Diseases

The Editor’s Roundtable: Psoriasis, Inflammation, and Coronary Artery Disease

Impact of ixekizumab treatment on skin‐related personal relationship difficulties in moderate‐to‐severe psoriasis patients: 12‐week results from two Phase 3 trials

The efficacy of multiple courses of alefacept in patients with moderate to severe chronic plaque psoriasis

Efficacy of Secukinumab on Moderate-to-severe Plaque Psoriasis Affecting Different Body Regions: a Pooled Analysis of Four Phase 3 Studies

Extreme obesity may be linked to markers flanking the human OB gene

EMERGING NEW THERAPIES FOR CUTANEOUS T-CELL LYMPHOMA

Ichthyosiform sarcoidosis

Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial

Suchergebnisse filtern